Drug Shortage Report for TEVA-FAMOTIDINE

Last updated on 2020-03-10 History
Report ID 94880
Drug Identification Number 02022141
Brand name TEVA-FAMOTIDINE
Common or Proper name TEVA-FAMOTIDINE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FAMOTIDINE
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-09-26
Estimated end date 2020-03-31
Actual end date 2020-03-09
Shortage status Resolved
Updated date 2020-03-10
Company comments Resolved
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2020-03-10 English Compare
v21 2020-03-09 French Compare
v20 2020-03-09 English Compare
v19 2019-12-05 French Compare
v18 2019-12-05 English Compare
v17 2019-11-14 French Compare
v16 2019-11-14 English Compare
v15 2019-11-14 English Compare
v14 2019-10-31 French Compare
v13 2019-10-31 English Compare
v12 2019-10-10 French Compare
v11 2019-10-10 English Compare
v10 2019-10-03 French Compare
v9 2019-10-03 English Compare
v8 2019-09-27 English Compare
v7 2019-09-26 French Compare
v6 2019-09-26 English Compare
v5 2019-09-26 French Compare
v4 2019-09-26 English Compare
v3 2019-09-26 French Compare

Showing 1 to 20 of 22